Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep627 | Obesity and cardiovascular endocrinology | ECE2015

Irisin/leptin ratio, a biological marker of lean/fat mass, may help to identify LMNA-mutated familial partial lipodystrophies

Bensmaine Faiza , Mapihan Kristell Le , Bourry Samuel , Lion Georges , Vigouroux Corinne , Pigny Pascal , Vantyghem Marie Christine

Irisin is a myokine correlated with lean body mass, despite its association with cardiovascular events (Mantzoros 2014). Increased muscle volume and lipoatrophy have been reported in female FPLD (Ji JCEM 214). Our aim was to determine whether irisin could help to distinguish certain lipodystrophic obesities from FPLD.Methods and patients: Circulating irisin levels (EIA Phoenix) were measured in 20 LMNA-related FPLD, 19 normal-weighed controls (H) and 13 ...

ea0090p536 | Late-Breaking | ECE2023

Role of insulin therapy in weight gain: lessons from islet transplantation in type1 diabetes

Romain Bulois , Jannin Arnaud , Defrance Frederique , Mapihan Kristell Le , Mikael Chetboun , Julie Kerr-Conte , Francois Pattou , Vantyghem Marie-Christine

Background: Weight gain in type 1 diabetes (T1D) patients has become a clinical problem due to less strict diets and more stringent glycemic targets. Thus, the number of overweight T1D in the USA increased from 3.4% in 1988 to 22.7% in 2007. Hyperinsulinism is involved in the genesis of obesity but in T1D, the impact of insulin therapy in weight gain is not established. Islet transplantation, now reimbursed in France, makes it possible to interrupt insulin. The aim of this wor...